The EYA4 gene helps control how certain cells develop and stay healthy, especially in the inner ear and sometimes the heart. This gene plays an important role in keeping hearing pathways working over time. If you carry a pathogenic variant in the EYA4 gene, hearing may gradually become less clear, often starting after speech has developed, and some people also develop a heart muscle condition called dilated cardiomyopathy. EYA4 is mainly discussed in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when certain processes happen, where they happen, and how active they are. As a group, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. To go further into this topic, you can find more in the LearnHub.
Overview
EYA4Gene function
What if the gene works
The EYA4 gene helps control how certain cells grow and mature, especially in the inner ear. Its protein also supports signals that help hearing structures and heart muscle work normally.
Risk
What if the gene does not work
Variants in the EYA4 gene most often cause progressive hearing loss that can begin from childhood to adulthood and range from mild to more marked. Some more disruptive variants have also been linked to dilated cardiomyopathy, a heart muscle condition.
Treatment
What does that mean for your treatment
No EYA4-specific treatment or drug selection is currently established in clinical guidelines. Care is based on the person's hearing or heart findings, such as standard hearing support, rather than a treatment chosen because of the EYA4 gene itself. EYA4 is being studied in cancer research as a possible biomarker, but this has not led to routine gene-directed treatment.
Conditions associated with EYA4
Gene function
What if the gene works
In many tissues, the EYA4 gene helps manage which other genes are active at the right time. When it works as expected, cells can follow growth and maintenance instructions in an orderly way. This is part of normal EYA4 gene function in hearing-related cells and other tissues that depend on precise gene control.
The EYA4 gene helps switch sets of genes on or off at the right time. It usually does this by working with partner proteins that guide cell instructions.
This gene supports normal tissue growth and shaping during early development. Its activity is especially important in structures involved in hearing, where cells need clear timing cues.
The EYA4 protein can remove small phosphate tags, which cells use as signals on proteins. This helps fine tune routine cell messages so activity stays organized.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many EYA4 gene variants reduce the amount of working protein a cell can make, often by creating a premature stop signal that causes RNA breakdown before the protein is finished. Other changes, especially missense variants in the conserved EYA region, can alter protein shape or partner binding. The pattern of how EYA4 gene variants affect hearing varies: milder changes may leave partial activity, while more severe loss of function can be linked to earlier or more marked hearing loss.
How variants are linked to conditions
Certain variants in the EYA4 gene cause an inherited form of hearing loss, often called DFNA10. Hearing usually worsens gradually and may begin after speech develops or later in adult life. In a smaller number of families, EYA4 variants have also been linked to dilated cardiomyopathy, a condition in which the heart becomes enlarged and pumps less well. Overall, the clearest EYA4 gene and inherited hearing loss association is progressive hearing loss.
A variant is not necessarily a diagnosis
Variants in our genes are a usual part of human biology and are common across the general population. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the EYA4 gene. In families with an EYA4 change, the main issue is often inherited hearing loss, and some people may also need heart follow-up depending on the exact change and family history.
Inheritance of EYA4 variants
EYA4-related conditions are usually inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in one copy of the EYA4 gene can pass it to a child, with a 50% chance in each pregnancy. In practical terms, how EYA4 gene variants are inherited often shows up as the condition being seen across several generations. Mothers and fathers can pass the variant to sons or daughters equally.
What does my EYA4 result mean for my family?
For many EYA4 results linked to inherited hearing loss, close relatives such as parents, brothers, sisters, and children may also carry the same gene change and may want to learn whether it runs in the family. A child of someone with a disease-causing EYA4 variant can have a 1 in 2, or 50%, chance of inheriting it. Some EYA4 variants have also been linked to heart muscle disease, so the meaning for family members depends on the exact result and condition involved.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the EYA4 gene, doctors use genetic testing for EYA4 variants, usually with a blood or saliva sample. A lab reads the DNA and compares it with the usual sequence to identify variants. Results may show a pathogenic variant, a benign variant, or a variant of uncertain significance (a change whose health effect is not yet clear).
When should I consider getting a genetic test?
Consider genetic testing for the EYA4 gene if hearing loss runs in your family, especially when it starts in adulthood and affects several generations. Testing can help explain an inherited cause of progressive hearing loss and may clarify risks for relatives.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on the condition and the specific type of variant. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed and more individualized treatment decisions. To explore this topic in greater detail, you can learn more in the LearnHub.
Drugs influenced by the EYA4 gene
When should I seek medical advice?
This gene is not currently used in a broadly confirmed way to guide medication choices, so questions about side effects, new symptoms, or how medicines may affect you are best discussed with your doctor.
History
In the late 1990s, researchers identified the EYA4 gene as the human relative of the fruit fly eyes absent gene, an important step in tracing how some developmental genes are shared across species. From these first observations, research expanded steadily. Soon afterward, studies linked variants in the EYA4 gene to inherited hearing loss in some families, helping explain a pattern that had been recognized across generations. Later reports connected certain EYA4 variants with hearing loss that can occur alongside heart muscle disease in a smaller number of families. Over time, descriptions became more precise as genetic testing improved and helped separate different EYA4 related patterns.